Overview
Investors searching QNT vs INJ usually want a clear market-cap and momentum snapshot. QNT prints $60.44 (-1.35%) while Injective is at $5.07 (+3.42%), with volume edge currently on Injective.
Quick winners
Full comparison
| Metric | QNT | INJ |
|---|---|---|
| Price | $60.44 | $5.07 |
| Market Cap | $879.22M | $490.41M |
| FDV | — | — |
| Volume 24h | $720,065.58 | $2.62M |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 72.00 | 99.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +3.50% | +5.78% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | QNT | INJ |
|---|---|---|
| 1H | — | — |
| 24H | -1.35% | +3.42% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | QNT | INJ |
|---|---|---|
| RSI | 54.31 | 53.92 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 66.45 | 0.29 |
| ADX | 20.44 | 12.69 |
| Support | 1,827.82 | 4.91 |
| Resistance | 1,960.30 | 5.47 |
| Trend | bearish | neutral |
| Momentum | 59.00 | — |
| Signal | neutral | neutral |
Automatic technical analysis
Technically, QNT shows RSI 54.31 with trend bias bearish, while Injective sits at RSI 53.92 (neutral). Divergences between momentum and price should be confirmed on higher timeframes.
Fundamentals
| Metric | QNT | INJ |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | — | 0.00 |
| Github activity | — | 118.00 |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
QNT
Injective
Pros and cons
Pros of QNT
- Market-cap scale on QNT may dampen some idiosyncratic shocks versus smaller peers.
- QNT typically benefits from deeper liquidity and broader market recognition inside the Top 300 set.
- Composite PEPS readings for QNT can surface clearer module agreement during trend phases.
Cons of QNT
- Crowded positioning around QNT sometimes amplifies squeeze or flush risk.
- Data gaps in niche fundamentals still apply — absence of a field is not confirmation.
- Large-cap status for QNT can mean slower percentage upside versus high-beta alternatives.
Pros of Injective
- Injective can offer higher relative beta when market attention rotates toward its niche.
- Active volume bursts on INJ sometimes precede sharper tactical moves.
- PEPS tracking for Injective still includes AI score and level context for monitoring.
Cons of Injective
- Relative underperformance versus QNT can persist through entire market regimes.
- Higher volatility on INJ cuts both ways and demands stricter risk limits.
- Trend failures on Injective often travel faster than on more established assets.
Which looks stronger right now?
On the latest snapshot, market-cap leadership belongs to QNT, while short-term performance leans toward Injective. That mix suggests relative strength can flip quickly, so size risk accordingly.
AI summary
Comparing QNT and INJ begins with structure: capitalization, volume and rank. Present prints are $60.44 versus $5.07. Momentum and trend can disagree with market-cap hierarchy. That is normal in crypto rotations and should be stress-tested against supports and news flow. Canonical URLs prevent duplicate INJ-vs-QNT pages, keeping SEO equity on one comparison. Keep monitoring winners as data updates.
FAQ
Which is better, QNT or Injective?
“Better” depends on horizon and risk. QNT leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, QNT or INJ?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both QNT and Injective.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. Injective currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.